Thynk Capital
Las Vegas, Nevadathynkcapital.com
Overview
Thynk Capital is a venture capital firm specializing in early-stage investments in Therapeutics, Healthcare, and Technology sectors . The firm focuses on companies dedicated to longevity and combating aging diseases, providing capital and critical value-added resources to optimize performance and increase enterprise value . Thynk Capital typically invests in Convertible Note, Seed, and Series A rounds, aiming to deliver above-market returns to its limited partners .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Repair Biotechnologies | Jun 2023 | Series A | Co-investor |
| Repair Biotechnologies | May 2022 | SAFE | Co-investor |
| Viscient Bio Inc | Sep 2021 | Convertible Debt | Co-investor |
| Viscient Bio Inc | May 2019 | Convertible Debt | Co-investor |
| Repair Biotechnologies | May 2019 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
